Patricia Clarkson stars in the movie “Lilly,” a biopic about former Alabama factory worker Lilly Ledbetter who became an ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

Our disagreement is about two portraits of her late husband she has hanging in her home, in plain sight for everyone who comes into the house to see. I have asked her to remove them, but she refuses.

James Dolan to Beyoncé: Hands Off My Sphere Sphere Entertainment Group sent Beyoncé a cease and desist over use of their orb in Cowboy Carter tour visuals. come to brazil! 6:28 p.m. Over 2 ...

Languages: English. You can get in touch with Alyce by emailing [email protected] A photographer who offered free portraits to anyone who stopped by was overcome with emotion when she heard ...

Marvel actor Jeremy Renner is revealing the near-fatal mistake that caused his snowplow incident in 2023. "'Before exiting ...

MOSCOW - A Russian artist who painted a portrait of Donald Trump that was given to the U.S. president by Vladimir Putin says he never suspected his work would become an instrument of Russia-U.S ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo ...

Eli Lilly (NYSE: NYSE:LLY) is set to report its first-quarter earnings on Thursday, May 1st, before the market opens. Analysts expect the drugmaker to earn $3.46 (+34.1% Y/Y) on revenue of $12.72B ...

Positive results for Eli Lilly's new diabetes and weight-loss drug have recently boosted its stock price. Data from several studies on the GLP-1 drug are expected to come out this year.

Eli Lilly is paying $13 million upfront, with $1 billion in biobucks up for grabs, for the opportunity to develop AI-designed oligonucleotide therapies from Creyon Bio. Oligonucleotides work as ...

The Alzheimer’s drug, MEDI1814, is an amyloid beta mAb that had been developed in collaboration with Eli Lilly in a pact dating back nearly a decade. Lilly, which markets its AD therapy Kisunla ...